95 related articles for article (PubMed ID: 2757648)
1. Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like properties.
Palfreyman MG; Dudley MW; Cheng HC; Mir AK; Yamada S; Roeske WR; Obata T; Yamamura HI
Biochem Pharmacol; 1989 Aug; 38(15):2459-65. PubMed ID: 2757648
[TBL] [Abstract][Full Text] [Related]
2. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
3. Interactions of calmodulin antagonists with calcium antagonists binding sites.
Schaeffer P; Lugnier C; Stoclet JC
Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Kenny BA; Fraser S; Spedding M
Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
[TBL] [Abstract][Full Text] [Related]
6. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel antagonist binding and pharmacology in rat uterine smooth muscle.
Grover AK; Oakes PJ
Life Sci; 1985 Dec; 37(23):2187-92. PubMed ID: 2933568
[TBL] [Abstract][Full Text] [Related]
8. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.
Spedding M
Br J Pharmacol; 1983 Nov; 80(3):485-8. PubMed ID: 6640202
[TBL] [Abstract][Full Text] [Related]
10. Effects of the calcium antagonists diltiazem, verapamil and nitrendipine on the contractile responses of guinea-pig isolated ileum to electrical stimulation or carbachol.
Staneva-Stoytcheva D; Venkova K
J Pharm Pharmacol; 1992 Apr; 44(4):321-5. PubMed ID: 1355544
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
Striessnig J; Meusburger E; Grabner M; Knaus HG; Glossmann H; Kaiser J; Schölkens B; Becker R; Linz W; Henning R
Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):331-40. PubMed ID: 2839780
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
Schoemaker H; Hicks PE; Langer SZ
J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
[TBL] [Abstract][Full Text] [Related]
13. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
[TBL] [Abstract][Full Text] [Related]
14. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
[TBL] [Abstract][Full Text] [Related]
15. Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
Spedding M; Mir AK
Br J Pharmacol; 1987 Oct; 92(2):457-68. PubMed ID: 2445406
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma.
Miwa N; Kanaide H; Nishimura J; Nakamura M
Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions between organic calcium channel antagonists in smooth muscle.
Yousif F; Triggle DJ
Can J Physiol Pharmacol; 1985 Mar; 63(3):193-5. PubMed ID: 3986704
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.
Thorgeirsson G; Rudolph SA
Biochem Biophys Res Commun; 1984 Jun; 121(2):657-63. PubMed ID: 6329206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
